Search clinical trials for: Byetta
Total 156 results
-
Albert Einstein College of MedicineCompleted
-
The University of Texas Health Science Center at...CompletedHealthy | Type 2 Diabetes | Impaired Glucose ToleranceUnited States
-
Joslin Diabetes CenterEli Lilly and Company; Amylin Pharmaceuticals, LLC.CompletedType 2 Diabetes MellitusUnited States
-
The University of Texas Health Science Center at...Amylin Pharmaceuticals, LLC.CompletedDiabetes | Impaired Glucose Tolerance (IGT)United States
-
University of California, Los AngelesAmylin Pharmaceuticals, LLC.Completed
-
Centre Hospitalier Universitaire de BesanconEli Lilly and Company; AstraZenecaCompleted
-
Jesper KjaergaardCompleted
-
Beth Israel Deaconess Medical CenterEli Lilly and Company; Amylin Pharmaceuticals, LLC.CompletedObesity | Impaired Glucose ToleranceUnited States
-
University of California, DavisEli Lilly and Company; Amylin Pharmaceuticals, LLC.TerminatedDiabetes Complications | Fatty LiverUnited States
-
University of Alabama at BirminghamAmylin Pharmaceuticals, LLC.TerminatedType 2 Diabetes Mellitus | Bone RemodelingUnited States
-
Baylor College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedType 2 DiabetesUnited States
-
Katarina KosDiabetes UKCompleted
-
Indiana UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Vanderbilt University Medical CenterCompletedObesity | Overweight | CraniopharyngiomaUnited States
-
University of MichiganEli Lilly and Company; Amylin Pharmaceuticals, LLC.CompletedType 2 Diabetes Mellitus | Diabetic Peripheral NeuropathyUnited States
-
PegBio Co., Ltd.Completed
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Completed
-
Katarina KosUniversity of ExeterTerminated
-
Christina KruuseCompleted
-
AstraZenecaCompletedType 2 DiabetesUnited States
-
Merck Sharp & Dohme LLCCompletedThe Methodology Assessment of Glucose Dependent Insulin Secretion
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Spain, Sweden, Argentina, Denmark, Finland, Hungary, Norway, Colombia, Austria, Greece, Puerto Rico
-
Uppsala UniversityAstraZeneca; Uppsala University HospitalCompleted
-
Stanford UniversityCompletedInsulin Resistance | Pre Diabetes
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusPhilippines
-
Children's Hospital Los AngelesCompletedPrader-Willi SyndromeUnited States
-
University of FloridaAmylin Pharmaceuticals, LLC.CompletedType 2 Diabetes Mellitus | Nonalcoholic Fatty Liver DiseaseUnited States
-
University Hospital, CaenEli Lilly and CompanyUnknown
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University Health Network, TorontoAstraZenecaUnknown
-
Baylor College of MedicineCompleted
-
Baylor College of MedicineCompletedType 2 Diabetes MellitusUnited States
-
Amsterdam UMC, location VUmcCompletedType 2 Diabetes Mellitus | Congestive Heart FailureNetherlands
-
Beijing Chao Yang HospitalUnknownCoronary Endothelial Function
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusCzech Republic, Italy, Poland, Spain, United Kingdom, Germany, Hungary, Finland, Mexico, Austria, France, Israel, Switzerland, Ireland
-
Assistance Publique Hopitaux De MarseilleCompleted
-
AstraZenecaCompletedType 2 Diabetes MellitusCanada, United States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Georgetown UniversityMedstar Health Research InstituteWithdrawnGestational DiabetesUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 DiabetesUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited Kingdom
-
Cornea Consultants Of NashvilleBausch & Lomb Incorporated; SCRI Development Innovations, LLCTerminatedCorneal UlcersUnited States
-
AstraZenecaEli Lilly and CompanyCompleted
-
Amsterdam UMC, location VUmcBristol-Myers Squibb; Eli Lilly and CompanyCompletedObesity | Diabetes Mellitus, Type 2 | Diabetes MellitusNetherlands
-
AstraZenecaEli Lilly and Company; i3 Drug SafetyCompletedType 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies) | Healthy Subjects (Treated With no Diabetes Therapies)United States
-
Intarcia TherapeuticsCompletedType 2 DiabetesUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Germany, Greece, Denmark, France
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusKorea, Republic of, China, Japan, Taiwan, India
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusAustralia, France, Italy, Korea, Republic of, Mexico, Spain, Poland, Romania, South Africa, Argentina, Austria, Belgium, Germany, Hungary, Israel, Slovakia, Greece, India, Taiwan, Canada, Czech Republic